The functional relevance of CXCR3 has been extensively characterized in T lymphocytes, particularly within the pathophysiological context of autoimmune disorders, infections and oncological diseases, where its expression facilitates the targeted migration of effector T cells to sites of inflammation and tumor-associated microenvironments (39–42). Here, CXCR3 is linked to neoplasm.